Details of the Drug

General Information of Drug (ID: DMSBZGI)

Drug Name

MIVOBULIN ISETHIONATE

Synonyms

Mivobulin isethionate < Prop INNM; (-)-(S)-N-(5-Amino-2-methyl-3-phenyl-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamic acid ethyl ester 2-hydroxyethylsulfonate

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H25N5O6S
Canonical SMILES: CCOC(=O)NC1=NC(=C2C(=C1)NC(C(=N2)C3=CC=CC=C3)C)N.C(CS(=O)(=O)O)O
InChI: 1S/C17H19N5O2.C2H6O4S/c1-3-24-17(23)21-13-9-12-15(16(18)20-13)22-14(10(2)19-12)11-7-5-4-6-8-11;3-1-2-7(4,5)6/h4-10,19H,3H2,1-2H3,(H3,18,20,21,23);3H,1-2H2,(H,4,5,6)/t10-;/m0./s1
InChIKey: JEFPWOBULVSOTM-PPHPATTJSA-N

Cross-matching ID

PubChem CID: 182762
CAS Number: 126268-81-3
TTD ID: D05UZO

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002442)